PEEK製インターボディデバイスの世界市場 - 2025年～2033年

世界のPEEK製インターボディデバイス市場は2024年に25億米ドルに達し、2033年には46億米ドルに達すると予測され、予測期間2025年から2033年のCAGRは7.4%で成長します。

PEEK（ポリエーテルエーテルケトン）製体幹部間器具は、高性能熱可塑性ポリマーで作られた医療用インプラントで、脊椎手術用に特別に設計されています。これらの器具は主に脊椎固定術で使用され、損傷または変性した椎間板の代わりとなり、隣接する椎骨の融合を促進することで脊椎を安定させる。PEEKは、高強度、高剛性、耐摩耗性、耐劣化性などの優れた機械的特性で知られる生体適合性ポリマーです。

PEEK製インターボディデバイスは、頚椎前方椎間板切除・固定術（ACDF）、腰椎椎体間固定術（LIF）、腰椎後方椎体間固定術（PLIF）、経椎間的腰椎椎体間固定術（TLIF）の手術で最も一般的に使用されています。これらの製品は、治癒と癒合のプロセスにおいて長期的なサポートを提供することを目的としています。

PEEK（ポリエーテルエーテルケトン）製椎体間固定器具の市場需要は、脊椎手術の進歩、医療ニーズの高まり、科学的分析による材料としてのPEEKのユニークな利点などに関する様々な要因により、長年にわたり着実に増加しています。例えば、米国国立衛生研究所（NIH）によると、PEEK製インターボディデバイスを使用した5つの研究（146症例）が最終的な解析に含まれており、その内訳は無作為化比較試験1件、前向き研究2件、後向き研究2件でした。これら5つの研究におけるPEEK製インターボディデバイスの融合率は88％から98％でした。

市場力学：

促進要因と抑制要因

PEEK製インターボディデバイスの技術的進歩の高まり

PEEK製インターボディデバイスにおける技術的進歩の高まりは、市場の成長を大きく後押ししており、予測期間中も市場を牽引していくと予想されます。これらの進歩により、PEEKインプラントの性能、カスタマイズ性、汎用性が強化され、脊椎手術で好まれる選択肢となっています。3Dプリンティング（積層造形）技術の使用により、患者固有の脊椎解剖学的構造に合わせたパーソナライズドPEEK製インターボディデバイスの作成が可能になります。これにより、手術の精度が向上し、合併症が減少し、癒合が成功する可能性が高まる。

例えば、2024年6月、主要技術・製造企業であるキュリテバ社は、FDA認可のInspire Posterior Interbody Fusion Solutionsの最初の製品を商業的に発売しました。HAFUSEテクノロジー搭載の3DプリントトラベキュラーPEEK製インターボディは、最適化された相互連結多孔質構造を誇り、デバイス全体への骨の成長を促進します。

PEEKの放射線透過性特性により、術後のX線およびCTスキャンが明瞭になり、金属インプラントの干渉を受けずに治癒プロセスをモニターするのに非常に重要です。これは、従来のチタン製インプラントと比較して、特に長期的なモニタリングに有利です。回復と術後ケア中の正確なモニタリングに対する需要の高まりが、市場におけるPEEKインプラントの成長を後押ししています。外科医がPEEKを好むのは、より良好なイメージングを可能にし、患者満足度の向上と合併症の減少につながるからです。

代替材料との競合

代替材料との競合は、PEEK製インターボディデバイス市場の成長を妨げる重要な課題の一つです。PEEKには多くの利点があるが、脊椎固定手術にも使用される他の材料が利用可能なため、市場シェアが制限される可能性があります。チタンは、その優れたオッセオインテグレーション特性、生体適合性、骨の成長をサポートする能力により、脊椎インプラントで最も一般的に使用されている材料の一つです。PEEKとは異なり、チタンには骨の成長を促す自然な粗い表面があり、多くの場合、より迅速で効果的な脊椎固定につながります。

チタンベースのインターボディデバイスは、特に高い癒合率を必要とする患者にとって、PEEKインプラントの直接の競合相手です。これらのインプラントは脊椎手術で実績があり、PEEKの強力な競争相手となります。炭素繊維強化PEEK（CFR-PEEK）インプラントは、PEEKと炭素繊維の利点を組み合わせることで、機械的特性と患者の予後を改善し、代替品として台頭してきています。脊椎手術におけるCFRP代替品の使用増加により、従来のPEEK製器具の市場需要は減少しています。

セラミックベースのインプラントは、優れた生体適合性とオッセオインテグレーションで知られています。これらの材料は骨結合を強化する能力があり、特に脊椎固定手術において、金属とPEEKインプラントの両方に代わる選択肢を提供します。セラミックは、より良い骨成長を促し、長期的なインプラント合併症を減らすという点で、競合優位性を提供します。セラミックが医療界で認知されるにつれ、PEEK製インターボディデバイスの需要が減少する可能性がある。

生体吸収性材料（ポリ-L-乳酸やその他の生体吸収性ポリマーなど）は、時間の経過とともに徐々に分解され、体内に吸収されるため、脊椎外科手術で注目されている新しいクラスの材料です。そのため、癒合完了後にインプラントを除去する手術が不要となり、患者によっては非常に魅力的な選択肢となります。生体吸収性インプラントの強度と性能が向上するにつれ、永久的な脊椎インプラントの必要性をなくすことができるため、PEEK製インプラントの競合相手としての地位が高まっています。

目次

第1章 市場イントロダクションと範囲

• 報告書の目的
• 調査範囲と定義
• 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

• 市場のハイライトと戦略的ポイント
• 主な動向と将来の予測
• 製品タイプ別のスニペット
• エンドユーザーによる抜粋
• 地域別スニペット

第3章 市場力学

• 影響要因
  • 促進要因
    • PEEK製インターボディデバイスにおける技術進歩の高まり
  • 抑制要因
    • 代替材料との競合
  • 機会
  • 影響分析

第4章 戦略的洞察と業界展望

• 市場のリーダーと先駆者
  • 新たな先駆者と著名な企業
  • 最大の売上を誇るブランドを確立したリーダー
  • 確立された製品を持つ市場リーダー
• 新興スタートアップ企業と主要イノベーター
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格市場力学

第5章 PEEK製インターボディデバイス市場、製品タイプ別

• 椎体間固定装置
• 前方腰椎椎体間固定装置（ALIF）
• 極限外側椎体間固定装置（XLIF）
• 後方腰椎椎体間固定装置（PLIF）
• 経椎間孔腰椎椎体間固定装置（TLIF）
• その他

第6章 PEEK製インターボディデバイス市場、エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第7章 PEEK製インターボディデバイス市場、地域別、市場分析と成長機会

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第8章 競合情勢と市場ポジショニング

• 競合状況の概要と主要な市場企業
• 市場シェア分析とポジショニングマトリックス
• 戦略的パートナーシップ、合併、買収
• 製品ポートフォリオとイノベーションにおける主な発展
• 企業ベンチマーク

第9章 企業プロファイル

• Stryker Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
  • SWOT分析
• Globus Medical, Inc.
• B. Braun SE
• Xtant Medical
• Invibio Ltd.
• ATEC Spine, Inc
• Life Spine, Inc.
• Orthofix Medical Inc.
• Curiteva, Inc.
• Intelivation Technologies

第10章 仮定と調査手法

• データ収集方法
• データの三角測量
• 予測技術
• データの検証と検証

第11章 付録

The global PEEK interbody devices market reached US$ 2.5 billion in 2024 and is expected to reach US$ 4.6 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.

PEEK (Polyether Ether Ketone) interbody devices are medical implants made from a high-performance thermoplastic polymer, designed specifically for use in spinal surgeries. These devices are primarily used in spinal fusion procedures, where they help stabilize the spine by replacing damaged or degenerated intervertebral discs and promoting the fusion of adjacent vertebrae. PEEK is a biocompatible polymer known for its excellent mechanical properties, including high strength, stiffness, and resistance to wear and degradation.

PEEK interbody devices are most commonly used in anterior cervical discectomy and fusion (ACDF), lumbar interbody fusion (LIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) surgeries. They are intended to provide long-term support during the healing and fusion process.

The market demand for PEEK (Polyether Ether Ketone) interbody devices has been steadily increasing over the years due to various factors related to advancements in spinal surgery, growing healthcare needs, and the unique benefits of PEEK as a material with scientific analysis. For instance, according to the National Institute of Health (NIH), five studies using PEEK interbody devices (146 patients) were included in the final analysis, including 1 randomized controlled trial, 2 prospective studies, and 2 retrospective studies. Rates of fusion for PEEK interbody devices in these 5 studies were 88% to 98%.

Market Dynamics: Drivers & Restraints

Rising technological advancements in PEEK interbody devices

The rising technological advancements in PEEK interbody devices are significantly driving the growth of the market and are expected to drive the market over the forecast period. These advancements are enhancing the performance, customization, and versatility of PEEK implants, making them a preferred choice in spinal surgeries. The use of 3D printing (additive manufacturing) technology allows for the creation of personalized PEEK interbody devices tailored to a patient's unique spinal anatomy. This improves the accuracy of surgeries, reduces complications, and enhances the chances of successful fusion.

For instance, in June 2024, Curiteva, Inc., a leading technology and manufacturing company, commercially launched the first of many offerings in its FDA-cleared Inspire Posterior Interbody Fusion Solutions. Developed to enhance patient outcomes of transforaminal lumbar procedures, this 3D Printed Trabecular PEEK with HAFUSE Technology interbody boasts an optimized interconnected porous structure, promoting bone ingrowth into and through the entire device.

PEEK's radiolucent properties allow for clear X-ray and CT scans post-surgery, which is crucial for monitoring the healing process without interference from metallic implants. This provides an advantage over traditional titanium implants, particularly for long-term monitoring. The increasing demand for precise monitoring during recovery and post-operative care is pushing the growth of PEEK implants in the market. Surgeons prefer PEEK for its ability to allow for better imaging, leading to greater patient satisfaction and fewer complications.

Competition from alternative materials

Competition from alternative materials is one of the key challenges hampering the growth of the PEEK interbody devices market. Although PEEK offers many advantages, the availability of other materials that are also used for spinal fusion surgeries can limit its market share. Titanium remains one of the most commonly used materials in spinal implants due to its superior osseointegration properties, biocompatibility, and ability to support bone growth. Unlike PEEK, titanium has natural rough surfaces that encourage bone growth, often leading to quicker and more effective spinal fusion.

Titanium-based interbody devices are a direct competitor to PEEK implants, particularly for patients who require enhanced fusion rates. These implants have a proven track record in spinal surgeries, making them a strong competitor for PEEK. Carbon fiber-reinforced PEEK (CFR-PEEK) devices are emerging as an alternative, combining the benefits of PEEK and carbon fiber for improved mechanical properties and patient outcomes. This increased use of CFRP alternatives in spinal surgeries reduces the market demand for traditional PEEK devices.

Ceramic-based implants are known for their excellent biocompatibility and osseointegration. These materials offer the ability to enhance bone bonding and provide an alternative to both metal and PEEK implants, particularly in spinal fusion surgeries. Ceramics offer a competitive edge in terms of promoting better bone growth and reducing long-term implant complications. As they gain recognition in the medical community, their adoption may reduce demand for PEEK interbody devices.

Bioresorbable materials (such as poly-L-lactic acid and other bioabsorbable polymers) are a new class of materials gaining attention in spinal surgery because they gradually break down and are absorbed by the body over time. This eliminates the need for implant removal surgery after fusion is complete, making them a highly attractive alternative for some patients. As bioresorbable implants improve in terms of strength and performance, their ability to eliminate the need for permanent spinal implants positions them as a growing competitor to PEEK devices.

For more details on this report - Request for Sample

Segment Analysis

The global PEEK interbody devices market is segmented based on product type, end-user and region.

Product Type:

The posterior lumbar interbody fusion devices segment is expected to dominate the PEEK interbody devices market share

One of the most notable benefits of using PEEK in posterior lumbar interbody fusion (PLIF) surgeries is its radiolucency. PEEK allows for clear post-surgical imaging (X-rays, CT scans), enabling better monitoring of the healing process without interference from the implant. This is particularly valuable in PLIF, where precise imaging is crucial to ensure the fusion process is proceeding correctly.

The adoption of minimally invasive spine surgery techniques, including minimally invasive PLIF (MIS-PLIF), is growing globally, especially in developed regions like the U.S. and Europe. PEEK's compatibility with minimally invasive spine surgery, due to its precise fit and ease of use, is fueling its dominance in posterior lumbar interbody fusion surgeries.

The growing preference for minimally invasive procedures, which involve smaller incisions and quicker recovery times, is driving the demand for PEEK interbody devices, particularly in PLIF surgeries, as they help enhance success rates and reduce surgical complications. Thus, many market players and emerging startups are focussing on the development of posterior interbody fusion devices with advanced features.

For instance, in October 2021, NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, launched the Cohere TLIF-O implant and the Cohere TLIF-A implant. With these additions to its Advanced Materials Science (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.

Geographical Analysis

North America is expected to hold a significant position in the PEEK interbody devices market share

North America, particularly the United States has a high incidence of degenerative disc disease, herniated discs and other spinal disorders, which drive the demand for spinal surgeries, including those using PEEK interbody devices. The aging population and lifestyle-related conditions contribute to the growing prevalence of spinal issues.

Additionally, according to the National Institute of Health (NIH), approximately 900,000 American and 30,000 Canadian adults undergo spine surgery annually. This rising number of spinal surgeries in North America especially in the United States and Canada directly boosts the demand for PEEK interbody devices, making the region the largest market for these implants.

The United States leads in the adoption of advanced surgical techniques such as minimally invasive spine surgery, which requires highly precise and biocompatible materials like PEEK. The use of PEEK interbody devices in PLIF (Posterior Lumbar Interbody Fusion) and other spinal fusion procedures is common in MISS due to its strength, radiolucency, and compatibility with modern imaging techniques.

Asia-Pacific is growing at the fastest pace in the PEEK interbody devices market

As the population in Asia-Pacific countries ages and urbanization increases, the incidence of spinal disorders such as degenerative disc disease, scoliosis, and herniated discs is rising. This has resulted in greater demand for spinal surgeries, including posterior lumbar interbody fusion (PLIF), anterior lumbar interbody fusion (ALIF), and other spinal fusion procedures that require interbody devices like PEEK. According to Clearstate, in 2022, an estimated total of 47k implanted spinal procedures were performed across SEA countries. As spinal procedures are growing in the region, many market players are expanding their spinal portfolio into PEEK interbody devices market.

For instance, in June 2022, an established strategic partnership between Beijing Fule and Invibio Biomaterial Solutions has resulted in the development of a new generation of interbody fusion devices, the first such high-performance material medical fusion cage product based upon PEEK-OPTIMATM HA Enhanced polymers in China.

Over the past decade, countries in APAC, such as India, China, Japan, and South Korea, have significantly improved their healthcare infrastructure. The adoption of advanced medical technologies like PEEK interbody devices has been a major factor in this growth. Many hospitals and surgical centers now offer world-class spine surgeries using cutting-edge technologies. APAC countries, particularly India, Thailand, and Singapore, have become global hubs for medical tourism due to cost-effective treatments combined with high-quality healthcare services. Spinal surgeries, including those using PEEK devices, are increasingly popular among medical tourists from the U.S., Europe, and the Middle East.

Competitive Landscape

The major global players in the PEEK interbody devices market include Stryker Corporation, Globus Medical, Inc., B. Braun SE, Xtant Medical, Invibio Ltd., ATEC Spine, Inc., Life Spine, Inc, Orthofix Medical Inc., Curiteva, Inc., Intelivation Technologies and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global PEEK interbody devices market report delivers a detailed analysis with 54 key tables, more than 46 visually impactful figures, and 147 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Product Type
• 2.4. Snippet by End-User
• 2.5. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Technological Advancements in PEEK Interbody Devices
  • 3.1.2. Restraints
    • 3.1.2.1. Competition From Alternative Materials
  • 3.1.3. Opportunity
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. Emerging Startups and Key Innovators
• 4.3. CXO Perspectives
• 4.4. Latest Developments and Breakthroughs
• 4.5. Case Studies/Ongoing Research
• 4.6. Regulatory and Reimbursement Landscape
  • 4.6.1. North America
  • 4.6.2. Europe
  • 4.6.3. Asia Pacific
  • 4.6.4. Latin America
  • 4.6.5. Middle East & Africa
• 4.7. Porter's Five Force Analysis
• 4.8. Supply Chain Analysis
• 4.9. Patent Analysis
• 4.10. SWOT Analysis
• 4.11. Unmet Needs and Gaps
• 4.12. Recommended Strategies for Market Entry and Expansion
• 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.14. Pricing Analysis and Price Dynamics

5. PEEK Interbody Devices Market, By Product Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 5.1.2. Market Attractiveness Index, By Product Type
• 5.2. Interbody Fusion Devices*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Anterior Lumbar Interbody Fusion Devices (ALIF)
• 5.4. Extreme Lateral Interbody Fusion Devices (XLIF)
• 5.5. Posterior Lumbar Interbody Fusion Devices (PLIF)
• 5.6. Transforaminal Lumbar Interbody Fusion Devices (TLIF)
• 5.7. Others

6. PEEK Interbody Devices Market, By End-User

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 6.1.2. Market Attractiveness Index, By End-User
• 6.2. Hospitals*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Specialty Clinics
• 6.4. Ambulatory Surgical Centers
• 6.5. Others

7. PEEK Interbody Devices Market, By Regional Market Analysis and Growth Opportunities

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 7.1.2. Market Attractiveness Index, By Region
• 7.2. North America
  • 7.2.1. Introduction
  • 7.2.2. Key Region-Specific Dynamics
  • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.2.5.1. U.S.
    • 7.2.5.2. Canada
    • 7.2.5.3. Mexico
• 7.3. Europe
  • 7.3.1. Introduction
  • 7.3.2. Key Region-Specific Dynamics
  • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.3.5.1. Germany
    • 7.3.5.2. U.K.
    • 7.3.5.3. France
    • 7.3.5.4. Spain
    • 7.3.5.5. Italy
    • 7.3.5.6. Rest of Europe
• 7.4. South America
  • 7.4.1. Introduction
  • 7.4.2. Key Region-Specific Dynamics
  • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.4.5.1. Brazil
    • 7.4.5.2. Argentina
    • 7.4.5.3. Rest of South America
• 7.5. Asia-Pacific
  • 7.5.1. Introduction
  • 7.5.2. Key Region-Specific Dynamics
  • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.5.5.1. China
    • 7.5.5.2. India
    • 7.5.5.3. Japan
    • 7.5.5.4. South Korea
    • 7.5.5.5. Rest of Asia-Pacific
• 7.6. Middle East and Africa
  • 7.6.1. Introduction
  • 7.6.2. Key Region-Specific Dynamics
  • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Stryker Corporation*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio and Description
  • 9.1.3. Financial Overview
  • 9.1.4. Key Developments
  • 9.1.5. SWOT Analysis
• 9.2. Globus Medical, Inc.
• 9.3. B. Braun SE
• 9.4. Xtant Medical
• 9.5. Invibio Ltd.
• 9.6. ATEC Spine, Inc
• 9.7. Life Spine, Inc.
• 9.8. Orthofix Medical Inc.
• 9.9. Curiteva, Inc.
• 9.10. Intelivation Technologies

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us